Expert Review of Clinical Pharmacology, published by TAYLOR & FRANCIS LTD, is a leading peer-reviewed journal dedicated to the field of clinical pharmacology, with a strong focus on the development and application of pharmacological therapies in patient care. Boasting an impressive impact, the journal ranks in the first quartile across multiple categories including Medicine (miscellaneous), Pharmacology (medical), and Pharmacology, Toxicology and Pharmaceutics (miscellaneous), reflecting its influential position within the scientific community. With a Scopus ranking of #6 in General Pharmacology, Toxicology and Pharmaceutics, the journal also achieves a commendable 93rd percentile, further emphasizing its importance as a resource for researchers and clinicians alike. As it continues to publish innovative reviews and research articles from 2008 until 2024, the Expert Review of Clinical Pharmacology plays an essential role in advancing knowledge, improving clinical practice, and fostering collaboration among experts in pharmacology, thereby driving forward the field's evolution towards better patient outcomes.

Psychotherapie is a pivotal academic journal dedicated to the exploration and advancement of clinical psychology, published by the esteemed Springer. Since its inception in 2022, this journal has established a significant footprint in the field, currently positioned in the Q3 category for Clinical Psychology in 2023, as well as being recognized for its Scopus ranking within the top half of its category. This valuable resource features a broad scope of peer-reviewed articles aimed at both theoretical and practical developments in psychotherapy, making it a vital platform for researchers, professionals, and students alike. While the journal is not open access, it maintains a commitment to disseminating high-quality research that can influence best practices and contribute to the ongoing discourse in psychology. The journal's editorial objective is to connect scientific research with clinical practice, ensuring insights garnered from emerging studies are readily available to enhance therapeutic outcomes. Located in the USA with a strong presence in Germany, Psychotherapie promises to be an essential resource for anyone keen on innovative therapeutical approaches and psychological research.

Journal of Pharmacological Sciences is a leading peer-reviewed academic journal dedicated to the field of pharmacology, published by the Japanese Pharmacological Society. Since its inception, this journal has offered an essential platform for the dissemination of high-quality research, contributing significantly to advancements in molecular medicine and pharmacology. With an impact factor that places it in the prestigious Q2 quartile for both categories, the journal has established itself as a credible source of innovative findings and methodologies since its transition to Open Access in 2015. This accessibility enables a broader audience, including researchers, healthcare professionals, and students, to engage with valuable insights and discussions pertinent to drug development, pharmacodynamics, and therapeutic strategies. Based in Kyoto, Japan, the journal serves as a vital resource for the global pharmacological community, encouraging collaboration and research that leads to improved health outcomes. For more information, submissions, and access to the latest research, visit the journal’s website.

AMERICAN JOURNAL OF PSYCHOTHERAPY, published by American Psychiatric Publishing, Inc, stands as a pivotal resource in the field of clinical psychology and psychotherapy, with an ISSN of 0002-9564 and an E-ISSN of 2575-6559. Since its inception in 1947, this esteemed journal has provided a rigorous platform for the dissemination of cutting-edge research, innovative clinical practices, and theoretical advancements in psychotherapy. With a respectable impact factor that places it in the Q2 quartile for both Clinical Psychology and Miscellaneous Medicine, it ranks in the 54th percentile among clinical psychology journals according to Scopus. The journal seeks to foster scholarly dialogue and inform evidence-based practices among researchers, practitioners, and students alike, encouraging the exploration of diverse therapeutic modalities and the integration of new research findings that enhance clinical outcomes. This commitment to academic excellence ensures that the AMERICAN JOURNAL OF PSYCHOTHERAPY remains an essential tool for those dedicated to the advancement of mental health care.

ARTS IN PSYCHOTHERAPY, published by Pergamon-Elsevier Science Ltd, stands as a prominent journal within the fields of Clinical Psychology and Health Professions. With the ISSN 0197-4556 for print and 1873-5878 for electronic formats, this journal has been contributing to the discourse on the therapeutic applications of arts since its inception in 1978. Operating out of the United Kingdom, the journal currently holds a Q2 ranking in both Clinical Psychology and Health Professions and features an impressive Scopus ranking among its peers, solidifying its role in advancing research in psychotherapy. Although it does not offer open access, the journal meticulously reviews submissions to provide a platform for innovative research and practices that integrate artistic modalities into psychological treatment. In a rapidly evolving mental health landscape, ARTS IN PSYCHOTHERAPY is essential reading for researchers, clinicians, and students seeking to deepen their understanding of creative interventions and their efficacy in promoting mental well-being.

Psychology and Psychotherapy - Theory, Research and Practice is a premier academic journal published by Wiley, which has established itself as a critical platform for the dissemination of cutting-edge scholarship in the fields of psychology and psychotherapy. With a strong emphasis on both theoretical frameworks and practical applications, this journal serves a diverse audience that includes researchers, clinicians, and students alike. The journal holds a prestigious impact factor and consistently ranks in the Q1 category across multiple fields, including Clinical Psychology, Developmental and Educational Psychology, and Psychiatry and Mental Health. With a rich history dating back to the 1920s and ongoing contributions until 2024, Psychology and Psychotherapy provides open access options to ensure widespread dissemination of knowledge. By publishing empirical studies, reviews, and theoretical propositions, the journal aims to advance the understanding of psychological processes and the efficacy of therapeutic practices, thereby playing a vital role in the ongoing discourse within the mental health community.

DRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.

Indian Journal of Pharmaceutical Education and Research, published by the Association of Pharmaceutical Teachers of India, is a pivotal platform for scholarly discussion in the field of pharmacology, toxicology, and pharmaceutics. ISSN 0019-5464, this esteemed journal aims to foster the exchange of innovative research, clinical advancements, and educational practices within the pharmaceutical sciences community. As a Q3-ranked journal in its category as of 2023, it reflects a commitment to upholding the standards of academic excellence and contributes significantly to the ongoing development of pharmaceutical education. The journal is a valuable resource for researchers, professionals, and students, with content spanning various key areas including drug formulation, safety, and the latest trends in pharmaceutical education. By providing open access to its research and reviews, the journal ensures that vital information is disseminated widely, promoting collaboration and learning among stakeholders in the pharmaceutical sector. Based in Bangalore, India, the journal has been instrumental in highlighting regional research while fostering a global dialogue in pharmaceutical sciences. As it continues its journey from 2008 to 2024, it remains dedicated to impacting the field through rigorous peer-reviewed content and engaging with contemporary challenges in healthcare and education.

Annual Review of Pharmacology and Toxicology is a leading journal published by ANNUAL REVIEWS, renowned for its comprehensive and critical reviews of the fields of pharmacology and toxicology. With an esteemed history spanning from 1965 to the present and an impressive Q1 ranking in both categories, this journal stands at the forefront of scholarly communication in pharmacological sciences. Researchers are encouraged to submit cutting-edge studies that advance knowledge and innovation in drug development, safety assessments, and therapeutic practices. Although this journal does not currently offer Open Access options, it remains a vital resource for professionals and students who seek to stay updated with the latest high-impact research findings. The journal is indexed in Scopus, boasting remarkable rankings, including Rank #1 in Toxicology and Rank #4 in Pharmacology, reflecting its pivotal role in shaping the discourse in these dynamic fields.

ANNALS OF PHARMACOTHERAPY, published by SAGE PUBLICATIONS INC, is a leading journal in the realm of pharmacology and therapeutic science, dedicated to advancing research, clinical practice, and education in the field of medicine. With a solid history dating back to its first publication in 1981, this journal offers a platform for high-quality research articles that explore the latest innovations and methodologies in pharmacotherapy. Although it operates under a subscription-based model, the journal maintains a robust academic reputation, reflected in its Scopus ranking in the 68th percentile within the category of Medicine - Pharmacology (Rank #85/272). The impact factor is continually evolving, as is the scope, which encompasses a diverse range of topics from clinical trials to the therapeutic applications of newly-developed drugs. Researchers, professionals, and students alike will find valuable insights and cutting-edge research in the ANNALS OF PHARMACOTHERAPY, making it an essential resource for anyone engaged in the field of pharmacology.